[ad_1]
The move is aimed at preventing a reduction in the multibillion-rand amount paid by the consortium that delisted it from the JSE
29 June 2023 – 21:05
Private hospital operator Mediclinic, recently delisted from the JSE by a Remgro-led consortium, has opted not to pay a final dividend for the year to end-March to prevent reducing the multibillion-rand acquisition price paid by the consortium.
“The group’s dividend policy before the acquisition was to target a payout ratio of between 25% and 35% of full-year adjusted earnings. Mediclinic’s board may revise the policy at its discretion,” Remgro said on Thursday…
[ad_2]
Source link
